Physician
Internal Medicine
Dr. Gregory M. Brown, MD
|
|
Give Review
Gregory Brown practices Internal Medicine. He graduated from Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine He over the years received 1 awards: "Meaningful Use Stage 1 Certification". Gregory M. Brown, MD is also published. He has 41 publications published. The lastest publication: "Melatonin and brain inflammaging.' He accepts all Medicare patients.
Publications
- Melatonin and brain inflammaging.
- Biochemical and Structural Studies of Uncharacterized Protein PA0743 from Pseudomonas aeruginosa Revealed NAD+-dependent L-Serine Dehydrogenase.
- Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference.
- Therapeutic potential of melatonin and its analogs in Parkinson''s disease: focus on sleep and neuroprotection.
- Structure and activity of the Saccharomyces cerevisiae dUTP pyrophosphatase DUT1, an essential housekeeping enzyme.
- Cerebral epiphyseal proteins and melatonin modulate the hepatic and renal antioxidant defense of rats.
- Melatonin in mitochondrial dysfunction and related disorders.
- Measurement of melatonin in body fluids: standards, protocols and procedures.
- Melatonin agonists in primary insomnia and depression-associated insomnia: Are they superior to sedative-hypnotics?
- Melatonin--a pleiotropic, orchestrating regulator molecule.
- Great challenges to sleep medicine: problems and paradigms.
- Melatonin and its agonist ramelteon in Alzheimer''s disease: possible therapeutic value.
- A dual function of the CRISPR-Cas system in bacterial antivirus immunity and DNA repair.
- Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs.
- Structural insight into the mechanism of c-di-GMP hydrolysis by EAL domain phosphodiesterases.
- Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis.
- Structure and activity of the metal-independent fructose-1,6-bisphosphatase YK23 from Saccharomyces cerevisiae.
- Potential use of melatonergic drugs in analgesia: mechanisms of action.
- Malaria: therapeutic implications of melatonin.
- Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.
- Ramelteon: a review of its therapeutic potential in sleep disorders.
- Melatonin and its relevance to jet lag.
- Structural and biochemical characterization of the type II fructose-1,6-bisphosphatase GlpX from Escherichia coli.
- A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats.
- Functional and structural characterization of four glutaminases from Escherichia coli and Bacillus subtilis.
- Biochemical and structural characterization of a novel family of cystathionine beta-synthase domain proteins fused to a Zn ribbon-like domain.
- High throughput screening of purified proteins for enzymatic activity.
- Molecular basis of the antimutagenic activity of the house-cleaning inosine triphosphate pyrophosphatase RdgB from Escherichia coli.
- Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
- Genome-wide analysis of substrate specificities of the Escherichia coli haloacid dehalogenase-like phosphatase family.
- Molecular basis of formaldehyde detoxification. Characterization of two S-formylglutathione hydrolases from Escherichia coli, FrmB and YeiG.
- General enzymatic screens identify three new nucleotidases in Escherichia coli. Biochemical characterization of SurE, YfbR, and YjjG.
- The HD domain of the Escherichia coli tRNA nucleotidyltransferase has 2',3'-cyclic phosphodiesterase, 2'-nucleotidase, and phosphatase activities.
- Immortalized cells from the rat suprachiasmatic nucleus express functional melatonin receptors.
- AII amacrine cells express the MT1 melatonin receptor in human and macaque retina.
- Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm.
- MT(1) melatonin receptor in the human retina: expression and localization.
- Low-dose dexamethasone challenge in women with atypical major depression: pilot study.
- Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
- Association of Per3 length polymorphism with bipolar I disorder and schizophrenia.
Schools
Yale University School Of Medicine
Jackson Meml Hospital University Miami School Med
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Jackson Memorial Hospital - Jackson Health System -
Yale University School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Adina M. Ion, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miguel E. Gonzalez, MD |
|
|
Dr. Peter A. Ankoh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dinesh Khanna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond D. Dominick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nidsa I. Martir Cruz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anureet K. Brar, DO |
|
|
Dr. Dante V. Nuzzo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Momo Hlaing, MB |